• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫和特征基因集分析肿瘤及非肿瘤组织中的胃癌亚型

Gastric Cancer Subtypes in Tumour and Nontumour Tissues by Immunologic and Hallmark Gene Sets.

作者信息

Zheng Xia, Wang Yanzhong, Chen Yirui

机构信息

Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, Zhejiang 310016, China.

Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, Zhejiang 310016, China.

出版信息

J Oncol. 2022 Aug 27;2022:7887711. doi: 10.1155/2022/7887711. eCollection 2022.

DOI:10.1155/2022/7887711
PMID:36065314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9440817/
Abstract

A previous research study on differentiating gastric cancer (GC) into distinct subtypes or prognostic models was mostly based on GC tissues, which neglected the role of nontumour tissues in GC subtypes. The purpose of the research was to identify GC subtypes on the basis of tumour and adjacent nontumour tissues to assess the prognosis of GC patients. We characterized three GC subtypes on the basis of the immunologic and hallmark gene sets in GC and adjacent nontumour tissues: among them, the GC patients with subtype I had the longest survival time compared to patients with other subtypes. The classification was closely associated with stage and pathological stage of GC patients. A prognostic model containing two gene sets was constructed by LASSO analysis. Kaplan-Meier analysis showed that patients in the high-risk group survived longer than those in the low-risk group and the two prognostic genes sets in the model were strongly correlated with survival status. Then, GO and KEGG analyses and PPI network show that nontumour and tumour tissues are influencing the prognosis of GC patients in separate manners. In summary, we emphasized the prognostic value of nontumour tissue in GC patients and proposed a novel insight that both changes in tumour and nontumour tissues should be taken into account when selecting a treatment strategy for GC.

摘要

先前关于将胃癌(GC)分为不同亚型或预后模型的研究大多基于GC组织,而忽略了非肿瘤组织在GC亚型中的作用。该研究的目的是基于肿瘤组织和相邻非肿瘤组织来识别GC亚型,以评估GC患者的预后。我们根据GC组织和相邻非肿瘤组织中的免疫和特征基因集对三种GC亚型进行了特征描述:其中,与其他亚型的患者相比,I型GC患者的生存时间最长。该分类与GC患者的分期和病理分期密切相关。通过LASSO分析构建了一个包含两个基因集的预后模型。Kaplan-Meier分析表明,高风险组的患者比低风险组的患者存活时间更长,并且模型中的两个预后基因集与生存状态密切相关。然后,GO和KEGG分析以及PPI网络表明,非肿瘤组织和肿瘤组织以不同的方式影响GC患者的预后。总之,我们强调了非肿瘤组织在GC患者中的预后价值,并提出了一种新的观点,即在为GC选择治疗策略时应同时考虑肿瘤组织和非肿瘤组织的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/1e62656cad8a/JO2022-7887711.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/e9725992c69e/JO2022-7887711.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/ad9ab41e0692/JO2022-7887711.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/391087c36fb8/JO2022-7887711.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/a77a52623dae/JO2022-7887711.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/cbdfdc7d2b56/JO2022-7887711.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/cd8fba251399/JO2022-7887711.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/67b8b5cd5b9b/JO2022-7887711.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/1e62656cad8a/JO2022-7887711.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/e9725992c69e/JO2022-7887711.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/ad9ab41e0692/JO2022-7887711.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/391087c36fb8/JO2022-7887711.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/a77a52623dae/JO2022-7887711.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/cbdfdc7d2b56/JO2022-7887711.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/cd8fba251399/JO2022-7887711.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/67b8b5cd5b9b/JO2022-7887711.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb2/9440817/1e62656cad8a/JO2022-7887711.008.jpg

相似文献

1
Gastric Cancer Subtypes in Tumour and Nontumour Tissues by Immunologic and Hallmark Gene Sets.通过免疫和特征基因集分析肿瘤及非肿瘤组织中的胃癌亚型
J Oncol. 2022 Aug 27;2022:7887711. doi: 10.1155/2022/7887711. eCollection 2022.
2
Head and Neck Squamous Cell Carcinoma Subtypes Based on Immunologic and Hallmark Gene Sets in Tumor and Non-tumor Tissues.基于肿瘤和非肿瘤组织中免疫及特征基因集的头颈部鳞状细胞癌亚型
Front Surg. 2022 Feb 3;9:821600. doi: 10.3389/fsurg.2022.821600. eCollection 2022.
3
A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients' Immunological Activity.基于乳腺癌患者免疫活性变化的乳腺癌亚型相关核糖体预后特征。
Medicina (Kaunas). 2023 Feb 21;59(3):424. doi: 10.3390/medicina59030424.
4
HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues.基于肿瘤和非肿瘤组织中免疫和标志性基因集活性变化的 HCC 亚型。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbaa427.
5
INPP4B exerts a dual role in gastric cancer progression and prognosis.INPP4B在胃癌进展和预后中发挥双重作用。
J Cancer. 2021 Oct 22;12(23):7201-7213. doi: 10.7150/jca.58397. eCollection 2021.
6
Identification of Novel Subtypes in Lung Adenocarcinoma: Evidence from Gene Set Variation Analysis in Tumor and Adjacent Nontumor Samples.肺腺癌新型亚型的鉴定:肿瘤和相邻非肿瘤样本的基因集变异分析证据。
Dis Markers. 2022 Jan 19;2022:2602812. doi: 10.1155/2022/2602812. eCollection 2022.
7
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.鉴定胃癌的新型生物标志物:黏蛋白 5AC(MUC5AC)、黏蛋白 1(MUC1)、角蛋白 7(KRT7)、甘油醛 3-磷酸脱氢酶(GAPDH)、CD44。
Med Oncol. 2020 Mar 27;37(5):34. doi: 10.1007/s12032-020-01362-0.
8
Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.胃癌中m6A相关基因的表达状态及预后价值
J Cancer. 2020 Mar 4;11(10):3027-3040. doi: 10.7150/jca.40866. eCollection 2020.
9
Molecular Typing of Gastric Cancer Based on Invasion-Related Genes and Prognosis-Related Features.基于侵袭相关基因和预后相关特征的胃癌分子分型
Front Oncol. 2022 Jun 3;12:848163. doi: 10.3389/fonc.2022.848163. eCollection 2022.
10
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.胃癌中 m6A 相关 lncRNAs 的肿瘤免疫微环境综合分析与预后评估。
BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8.

引用本文的文献

1
Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery.用于预测手术治疗 III 期胃癌患者预后的综合氧化应激评分。
Pathol Oncol Res. 2023 Jun 2;29:1610897. doi: 10.3389/pore.2023.1610897. eCollection 2023.

本文引用的文献

1
Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer.基于计算机断层扫描成像的放射组学分析揭示卵巢癌中的缺氧模式和免疫特征。
Front Immunol. 2022 Mar 28;13:868067. doi: 10.3389/fimmu.2022.868067. eCollection 2022.
2
Head and Neck Squamous Cell Carcinoma Subtypes Based on Immunologic and Hallmark Gene Sets in Tumor and Non-tumor Tissues.基于肿瘤和非肿瘤组织中免疫及特征基因集的头颈部鳞状细胞癌亚型
Front Surg. 2022 Feb 3;9:821600. doi: 10.3389/fsurg.2022.821600. eCollection 2022.
3
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
整合临床特征和组学分析确定了一个铁死亡和铁代谢相关的 lncRNA 特征,可用于预测卵巢癌的预后和治疗反应。
J Ovarian Res. 2022 Jan 20;15(1):10. doi: 10.1186/s13048-022-00944-y.
4
Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining.通过综合 TCGA 和 GEO 数据挖掘鉴定 MATN3 作为胃癌的新型预后生物标志物。
Dis Markers. 2021 Dec 2;2021:1769635. doi: 10.1155/2021/1769635. eCollection 2021.
5
IL-36γ and IL-36Ra Reciprocally Regulate NSCLC Progression by Modulating GSH Homeostasis and Oxidative Stress-Induced Cell Death.白细胞介素-36γ 和白细胞介素-36Ra 通过调节 GSH 稳态和氧化应激诱导的细胞死亡来相互调节非小细胞肺癌的进展。
Adv Sci (Weinh). 2021 Oct;8(19):e2101501. doi: 10.1002/advs.202101501. Epub 2021 Aug 8.
6
The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.基于深度学习的胃癌免疫亚型和全景预测及全 slides 图像分析。
Front Immunol. 2021 Jun 28;12:685992. doi: 10.3389/fimmu.2021.685992. eCollection 2021.
7
A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.基于特征的胃癌分类方法,可对肿瘤免疫进行分层,并预测对 PD-1 抑制剂的反应。
Front Immunol. 2021 Jun 11;12:693314. doi: 10.3389/fimmu.2021.693314. eCollection 2021.
8
Constructing a new prognostic signature of gastric cancer based on multiple data sets.基于多个数据集构建胃癌的新预后标志物。
Bioengineered. 2021 Dec;12(1):2820-2835. doi: 10.1080/21655979.2021.1940030.
9
Current treatment and recent progress in gastric cancer.胃癌的当前治疗方法和最新进展。
CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16.
10
Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.转录组谱分析鉴定出用于预测胃癌腹膜复发和微转移的风险分层特征。
Clin Cancer Res. 2021 Apr 15;27(8):2292-2300. doi: 10.1158/1078-0432.CCR-20-3835. Epub 2021 Feb 8.